Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
De Muynck K, Heyerick L, De Ponti FF, Vanderborght B, Meese T, Van Campenhout S, Baudonck L, Gijbels E, Rodrigues PM, Banales JM, Vesterhuus M, Folseraas T, Scott CL, Vinken M, Van der Linden M, Hoorens A, Van Dorpe J, Lefere S, Geerts A, Van Nieuwerburgh F, Verhelst X, Van Vlierberghe H, Devisscher L. De Muynck K, et al. Among authors: van vlierberghe h. Hepatology. 2024 Feb 1;79(2):269-288. doi: 10.1097/HEP.0000000000000557. Epub 2023 Aug 2. Hepatology. 2024. PMID: 37535809 Free PMC article.
Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma.
Vanderborght B, De Muynck K, Gijbels E, Lefere S, Scott CL, Guilliams M, Beschin A, Vinken M, Verhelst X, Geerts A, Van Vlierberghe H, Devisscher L. Vanderborght B, et al. Among authors: van vlierberghe h. Int J Cancer. 2023 Jun 15;152(12):2615-2628. doi: 10.1002/ijc.34505. Epub 2023 Mar 20. Int J Cancer. 2023. PMID: 36912275
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease.
Gijbels E, De Muynck K, Vanderborght B, Meese T, Van Nieuwerburgh F, Vanlander A, Berrevoet F, Hendrikx B, Hoorens A, Van Vlierberghe H, Vinken M, Devisscher L. Gijbels E, et al. Among authors: van vlierberghe h. Genes Dis. 2022 Mar 14;10(1):18-21. doi: 10.1016/j.gendis.2022.02.003. eCollection 2023 Jan. Genes Dis. 2022. PMID: 37013051 Free PMC article. No abstract available.
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
Degroote H, Piñero F, Costentin C, Notarpaolo A, Boin IF, Boudjema K, Baccaro C, Chagas AL, Bachellier P, Ettorre GM, Poniachik J, Muscari F, Di Benedetto F, Duque SH, Salame E, Cillo U, Gadano A, Vanlemmens C, Fagiuoli S, Rubinstein F, Burra P, Cherqui D, Silva M, Van Vlierberghe H, Duvoux C; French-Italian-Belgium and Latin American collaborative group for HCC and liver transplantation. Degroote H, et al. Among authors: van vlierberghe h. JHEP Rep. 2021 Jul 13;3(5):100331. doi: 10.1016/j.jhepr.2021.100331. eCollection 2021 Oct. JHEP Rep. 2021. PMID: 34485882 Free PMC article.
Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.
Butaye E, Somers N, Grossar L, Pauwels N, Lefere S, Devisscher L, Raevens S, Geerts A, Meuris L, Callewaert N, Van Vlierberghe H, Verhelst X. Butaye E, et al. Among authors: van vlierberghe h. Aliment Pharmacol Ther. 2024 Jan;59(1):23-38. doi: 10.1111/apt.17748. Epub 2023 Oct 25. Aliment Pharmacol Ther. 2024. PMID: 37877758 Review.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
An unusual cause of portal hypertension.
Ferdinande K, Lamiroy T, Hoorens A, Verhelst X, Degroote H, Raevens S, Van Vlierberghe H, Geerts A. Ferdinande K, et al. Among authors: van vlierberghe h. Acta Gastroenterol Belg. 2023 Jul-Sep;86(3):509-510. doi: 10.51821/86.3.11925. Acta Gastroenterol Belg. 2023. PMID: 37814574 Free article. No abstract available.
A remarkable presentation of a massive Budd-Chiari syndrome.
Ferdinande K, Degroote H, Geerts A, Van Vlierberghe H, Verhelst X, Raevens S. Ferdinande K, et al. Among authors: van vlierberghe h. Acta Gastroenterol Belg. 2023 Jul-Sep;86(3):503-504. doi: 10.51821/86.3.11994. Acta Gastroenterol Belg. 2023. PMID: 37814571 Free article. No abstract available.
335 results